Factor‐inhibiting HIF‐1 (FIH‐1) is required for human vascular endothelial cell survival
Open Access
- 2 April 2015
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 29 (7) , 2814-2827
Abstract
Factor‐inhibiting hypoxia‐inducible factor (HIF)‐1 (FIH‐1) is an asparaginyl β‐hydroxylase enzyme that was initially found to hydroxylate the HIF‐α, preventing its transcriptional activity and leading to adaptive responses to hypoxia. More recently, other substrates, such as neurogenic locus notch homolog (Notch), have been found to be alternative FIH targets, but the biologic relevance of this regulation was never investigated. Given the key function of Notch in angiogenesis, we here investigate the role of FIH/Notch signaling in endothelial cells. We report that FIH‐1 silencing in HUVECs results in reduced growth and increased apoptosis. The knockdown of FIH is associated with increased Notch2 activity, leading to enhanced expression of the Notch target hairy/enhancer‐of‐split related with YRPW motif protein 1 (Hey‐1). Consistent with recent findings showing that Notch2 suppresses survivin (a key inhibitor of apoptosis), FIH targeting in HUVECs leads to selective repression of survivin in endothelial cells, thus promoting cell apoptosis and growth arrest. Our data support the concept that FIH‐1 may interact with Notch2 and repress its activity, thereby playing a critical role in controlling the survival of vascular endothelial cells. These findings might pave the way toward novel, antiangiogenic strategies in disorders that are characterized by excessive vascular growth, such as cancer and rheumatoid arthritis.—Kiriakidis, S., Henze, A.‐T., Kruszynska‐Ziaja, I., Skobridis, K., Theodorou, V., Paleolog, E. M., Mazzone, M. Factor‐inhibiting HIF‐1 (FIH‐1) is required for human vascular endothelial cell survival. FASEB J . 29, 2814‐2827 (2015). www.fasebj.orgKeywords
Funding Information
- Fonds Wetenschappelijk Onderzoek (G.0718.10N)
- Stichting Tegen Kanker (2010‐169)
This publication has 54 references indexed in Scilit:
- Hypoxia—a key regulator of angiogenesis and inflammation in rheumatoid arthritisNature Reviews Rheumatology, 2012
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeuticsOncogene, 2009
- Regulation of Oxygen Homeostasis by Hypoxia-Inducible Factor 1Physiology, 2009
- Hypoxia-inducible Factor (HIF) Asparagine Hydroxylase Is Identical to Factor Inhibiting HIF (FIH) and Is Related to the Cupin Structural FamilyJournal of Biological Chemistry, 2002
- Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic SwitchScience, 2002
- FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activityGenes & Development, 2001
- C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl HydroxylationCell, 2001
- Mechanism of regulation of the hypoxia‐inducible factor‐1α by the von Hippel‐Lindau tumor suppressor proteinThe EMBO Journal, 2000
- The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysisNature, 1999